Xeureka Inc.

  • HOME
  • COMPANY
    • ABOUT US
    • OUR TEAM
  • SERVICE
    • Computational Drug Discovery Solution​​
    • Tokyo-1
  • NEWS
  • BLOG
  • CAREER
  • CONTACT

  • July 16, 2026

    “Tokyo-1” Featured in NVIDIA Blog

    READ MORE

  • June 02, 2026

    An Article on Protein AI Mentioning Xeureka’s “Tokyo-1” Published on Nikkei XTECH

    READ MORE

  • May 21, 2026

    Xeureka Achieves Lead Nomination Milestone in Collaborative Research with UBE

    READ MORE

  • May 13, 2026

    An Article Covering a Seminar Hosted by the Japan Pharmaceutical Manufacturers Association (JPMA) Published on the Nikkei

    READ MORE

  • April 02, 2026

    Xeureka and Sumitomo Pharma Announce a Collaborative Research Agreement for Small-Molecule Drug Discovery

    READ MORE

  • April 01, 2026

    Notice of Website Update

    READ MORE

  • February 18, 2026

    Our CTO Makiguchi to Speak at a Seminar Hosted by the Japan Pharmaceutical Manufacturers Association (JPMA)

    READ MORE

  • February 16, 2026

    Xeureka Held the Third Executive Board Meeting of Tokyo-1

    READ MORE

  • December 16, 2025

    Xeureka Launches Joint Research Collaboration with the Lokey Laboratory at UC Santa Cruz on the Membrane Permeability of Cyclic Peptides

    READ MORE

  • 1
  • 2
  • …
  • 4
INNOVATOR OF DRUG DISCOVERY THROUGH CONVERGENCE OF DRY & WET

COMPANY

  • About us
  • Our Team

SERVICE

  • Computational Drug Discovery Solution
  • Tokyo-1

CAREER

NEWS

BLOG

CONTACT

Xeureka Inc.
Toranomon 30 Mori Building 9F
3-2-2 Toranomon
Minato-ku, Tokyo 105-0001, Japan

© Xeureka Inc.

  • HOME
  • ABOUT US
  • OUR TEAM
  • SERVICE
  • CAREER
  • NEWS
  • BLOG
  • CONTACT
  • EN
  • JP